Kuehne + Nagel to invest in Switzerland for pharma logistics
		
			
			29/06/2017 - 15:52:00		
	
	Mayor Fredy Boeni, Klaus-Michael Kuehne, majority shareholder of Kuehne + Nagel International AG and Dr. Detlef Trefzger, CEO of Kuehne + Nagel International AG, attended the ground-breaking ceremony for the “Pharma Hub Switzerland”. 
    
	The Pharma Hub will be part of the KN PharmaChain network, providing multimodal temperature-controlled door-to-door shipping on a global scale, enhanced visibility and traceability of the deliveries, as well as intensive and proactive risk management. 
	The new Kuehne + Nagel logistics facility in Möhlin will provide 16,300 m2 of logistics space, which will be used to manage approximately 46,000 pallet spaces using a warehouse system that combines manual and automatic operation. Three different temperature zones will be available for the highly sensitive products: -20 degrees, -2 to +8 degrees, plus +15 to +25 degrees. In addition, hazardous goods and narcotics can be stored in dedicated areas.
	The Möhlin Pharma Hub will also focus on providing value-added services. The facility will provide end-to-end shipping and logistics services based on GxP-compliant standard. 
	Dr. Detlef Trefzger, CEO of Kuehne + Nagel International AG , said: “Switzerland is an important pharma location with global reach. The cutting-edge facility in Möhlin is a strategic investment in this growth sector and supports us to serve our customers even better, especially through integration with the global Kuehne + Nagel pharma network.”
  	
    